Any feedback?
Please rate this page
(enzyme.php)
(0/150)

BRENDA support

Reference on EC 3.4.24.75 - lysostaphin

Please use the Reference Search for a specific query.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
REF.
AUTHORS
TITLE
JOURNAL
VOL.
PAGES
YEAR
ORGANISM (UNIPROT)
PUBMED ID
SOURCE
Thumm, G.; Gtz, F.
Studies on prolysostaphin processing and characterization of lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus
Mol. Microbiol.
23
1251-1265
1997
Staphylococcus simulans
Manually annotated by BRENDA team
Baba, T.; Schneewind, O.
Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lyostaphin to the cell wall of Staphylococcus aureus
EMBO J.
15
4789-4797
1996
Staphylococcus simulans
Manually annotated by BRENDA team
Recsei, P.A.; Gruss, A.D.; Novick, R.P.
Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans
Proc. Natl. Acad. Sci. USA
84
1127-1131
1987
Staphylococcus simulans, Staphylococcus simulans NRRL B-2628
Manually annotated by BRENDA team
Woo Park, P.; Senior, R.M.; Griffin, G.L.; Broekelmann, T.J.; Mudd, M.S.; Mecham, R.P.
Binding and degradation of elastin by the staphylolytic enzyme lysostaphin
Int. J. Cell Biol.
27
139-146
1995
Staphylococcus simulans
Manually annotated by BRENDA team
Kline, S.A.; de la Harpe, J.; Blackburn, P.
A colorimetric microtiter plate assay for lysostaphin using a hexaglycine substrate
Anal. Biochem.
217
329-331
1994
Staphylococcus simulans
Manually annotated by BRENDA team
Sugai, M.; Akiyama, T.; Miyake, Y.; Ishida, E.; Suginaka, H.
Rapid purification method of lysostaphin for analysis of cell-wall proteins
J. Microbiol. Methods
12
133-138
1990
Staphylococcus simulans, Staphylococcus simulans NRRL B-2628
-
Manually annotated by BRENDA team
Cisani, G.; Varaldo, P.E.; Grazi, G.; Soro, O.
High-level potentiation of lysostaphin anti-staphylococcal activity by lysozyme
Antimicrob. Agents Chemother.
21
531-535
1982
Staphylococcus simulans
Manually annotated by BRENDA team
Robinson, J.M.; Hardman, J.K.; Sloan, G.L.
Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus
J. Bacteriol.
137
1158-1164
1979
Staphylococcus simulans
Manually annotated by BRENDA team
Iversen, O.J.; Grov, A.
Studies on lysostaphin. Separation and characterizateion of three enzymes
Eur. J. Biochem.
38
293-300
1973
Staphylococcus simulans, Staphylococcus simulans NRRL B-2628
Manually annotated by BRENDA team
Schindler, C.A.; Schuchardt, V.T.
Lysostaphin: a new bacteriolytic agent for the Staphylococcus
Proc. Natl. Acad. Sci. USA
51
414-421
1964
Staphylococcus sp., Staphylococcus sp. K-6-WI
Manually annotated by BRENDA team
Schindler, C.A.; Schuchardt, V.T.
Purification and properties of lysostaphin - a lytic agent for Staphylococcus aureus
Biochim. Biophys. Acta
97
242-250
1965
Staphylococcus sp., Staphylococcus sp. K-6-WI
Manually annotated by BRENDA team
Sugai, M.; Fujiwara, T.; Akiyama, T.; Ohara, M.; Komatsuzawa, H.; Inoue, S.; Suginaka, H.
Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1
J. Bacteriol.
179
1193-1202
1997
Staphylococcus capitis, Staphylococcus capitis EPK1
Manually annotated by BRENDA team
Trayer, H.R.; Buckley, C.E.
Molecular properties of lysostaphin, a bacteriolytic agent specific for Staphylococcus aureus
J. Biol. Chem.
245
4842-4846
1970
Staphylococcus simulans bv. staphylolyticus
Manually annotated by BRENDA team
Fedorov, T.V.; Surovtsev, V.I.; Pletnev, V.Z.; Borozdina, M.A.; Gusev, V.V.
Purification and some properties of lysostaphin, a glycylglycine endopeptidase from the culture liquid of Staphylococcus simulans biovar staphylolyticus
Biochemistry (Moscow)
68
50-53
2003
Staphylococcus simulans
Manually annotated by BRENDA team
Ramadurai, L.; Lockwood, K.J.; Nadakavukaren, M.J.; Jayaswal, R.K.
Characterization of a chromosomally encoded glycylglycine endopeptidase of Staphylococcus aureus
Microbiology
145
801-808
1999
Staphylococcus aureus
-
Manually annotated by BRENDA team
Szweda, P.; Pladzyk, R.; Kotlowski, R.; Kur, J.
Cloning, expression, and purification of the Staphylococcus simulans lysostaphin using the intein-chitin-binding domain (CBD) system
Protein Expr. Purif.
22
467-471
2001
Staphylococcus simulans (P10547), Staphylococcus simulans
Manually annotated by BRENDA team
Bochtler, M.; Odintsov, S.G.; Marcyjaniak, M.; Sabala, I.
Similar active sites in lysostaphins and D-Ala-D-Ala metallopeptidases
Protein Sci.
13
854-861
2004
Staphylococcus aureus
Manually annotated by BRENDA team
Koehl, J.L.; Muthaiyan, A.; Jayaswal, R.K.; Ehlert, K.; Labischinski, H.; Wilkinson, B.J.
Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus
Antimicrob. Agents Chemother.
48
3749-3757
2004
Staphylococcus simulans bv. staphylolyticus
Manually annotated by BRENDA team
Kusuma, C.M.; Kokai-Kun, J.F.
Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus
Antimicrob. Agents Chemother.
49
3256-3263
2005
Staphylococcus simulans
Manually annotated by BRENDA team
Surovtsev, V.I.; Fedorov, T.V.; Borozdina, M.A.
Michaelis-Menten kinetics for determining enzymatic activity of lysostaphin
Biochemistry
69
754-756
2004
Staphylococcus simulans
Manually annotated by BRENDA team
Park, P.W.; Mecham, R.P.
Lysostaphin
Handbook of Proteolytic Enzymes (Barrett, J. ; Rawlings, N. D. ; Woessner, J. F. , eds. ) Academic Press
1
1004-1005
2004
Staphylococcus simulans
-
Manually annotated by BRENDA team
Gruendling, A.; Schneewind, O.
Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus
J. Bacteriol.
188
2463-2472
2006
Staphylococcus simulans
Manually annotated by BRENDA team
Szweda, P.; Kotlowski, R.; Kur, J.
New effective sources of the Staphylococcus simulans lysostaphin
J. Biotechnol.
117
203-213
2005
Staphylococcus simulans (P10547), Staphylococcus simulans
Manually annotated by BRENDA team
Klein, M.; Kroenke, M.; Krut, O.
Expression of lysostaphin in HeLa cells protects from host cell killing by intracellular Staphylococcus aureus
Med. Microbiol. Immunol.
195
159-163
2006
Staphylococcus simulans
Manually annotated by BRENDA team
Warfield, R.; Bardelang, P.; Saunders, H.; Chan, W.C.; Penfold, C.; James, R.; Thomas, N.R.
Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus
Org. Biomol. Chem.
4
3626-3638
2006
Staphylococcus simulans
Manually annotated by BRENDA team
Sharma, R.; Sharma, P.R.; Choudhary, M.L.; Pande, A.; Khatri, G.S.
Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli
Protein Expr. Purif.
45
206-215
2006
Staphylococcus simulans
Manually annotated by BRENDA team
Turner, M.S.; Waldherr, F.; Loessner, M.J.; Giffard, P.M.
Antimicrobial activity of lysostaphin and a Listeria monocytogenes bacteriophage endolysin produced and secreted by lactic acid bacteria
Syst. Appl. Microbiol.
30
58-67
2006
Lactiplantibacillus plantarum, Limosilactobacillus fermentum, Lacticaseibacillus rhamnosus, Staphylococcus simulans, Limosilactobacillus fermentum BR11, Lacticaseibacillus rhamnosus GG
Manually annotated by BRENDA team
Gruendling, A.; Missiakas, D.M.; Schneewind, O.
Staphylococcus aureus mutants with increased lysostaphin resistance
J. Bacteriol.
188
6286-6297
2006
Staphylococcus simulans, Staphylococcus simulans TNK1
Manually annotated by BRENDA team
Yang, G.; Gao, Y.; Feng, J.; Huang, Y.; Li, S.; Liu, Y.; Liu, C.; Fan, M.; Shen, B.; Shao, N.
C-terminus of TRAP in Staphylococcus can enhance the activity of lysozyme and lysostaphin
Acta Biochim. Biophys. Sin.
40
452-458
2008
Staphylococcus simulans
Manually annotated by BRENDA team
Oluola, O.; Kong, L.; Fein, M.; Weisman, L.E.
Lysostaphin in treatment of neonatal Staphylococcus aureus infection
Antimicrob. Agents Chemother.
51
2198-2200
2007
Staphylococcus simulans
Manually annotated by BRENDA team
Surovtsev, V.I.; Borzenkov, V.M.; Fedorov, T.V.; Smotrov, O.I.
Ionogenic groups in the active site of lysostaphin. Kinetic and thermodynamic data compared with x-ray crystallographic data
Biochemistry (Moscow)
72
989-993
2007
Staphylococcus simulans
Manually annotated by BRENDA team
LaPlante, K.L.
In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus
Diagn. Microbiol. Infect. Dis.
57
413-418
2007
Staphylococcus simulans
Manually annotated by BRENDA team
Graham, S.; Coote, P.J.
Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin
J. Antimicrob. Chemother.
59
759-762
2007
Staphylococcus simulans
Manually annotated by BRENDA team
Kokai-Kun, J.F.; Chanturiya, T.; Mond, J.J.
Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model
J. Antimicrob. Chemother.
60
1051-1059
2007
Staphylococcus simulans
Manually annotated by BRENDA team
Yang, X.Y.; Li, C.R.; Lou, R.H.; Wang, Y.M.; Zhang, W.X.; Chen, H.Z.; Huang, Q.S.; Han, Y.X.; Jiang, J.D.; You, X.F.
In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from hospitals in Beijing, China
J. Med. Microbiol.
56
71-76
2007
Staphylococcus simulans
Manually annotated by BRENDA team
Tan, Y.P.; Giffard, P.M.; Barry, D.G.; Huston, W.M.; Turner, M.S.
Random mutagenesis identifies novel genes involved in the secretion of antimicrobial, cell wall-lytic enzymes by Lactococcus lactis
Appl. Environ. Microbiol.
74
7490-7496
2008
Lactococcus lactis
Manually annotated by BRENDA team
Kumar, J.K.
Lysostaphin: an antistaphylococcal agent
Appl. Microbiol. Biotechnol.
80
555-561
2008
Staphylococcus epidermidis, Staphylococcus simulans
Manually annotated by BRENDA team
Bardelang, P.; Vankemmelbeke, M.; Zhang, Y.; Jarvis, H.; Antoniadou, E.; Rochette, S.; Thomas, N.R.; Penfold, C.N.; James, R.
Design of a polypeptide fluorescence resonance energy transfer substrate that facilitates study of the antimicrobial protease lysostaphin
Biochem. J.
418
615-624
2009
Staphylococcus simulans
Manually annotated by BRENDA team
Becker, S.C.; Foster-Frey, J.; Donovan, D.M.
The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA
FEMS Microbiol. Lett.
287
185-191
2008
Staphylococcus simulans
Manually annotated by BRENDA team
Francius, G.; Domenech, O.; Mingeot-Leclercq, M.P.; Dufrene, Y.F.
Direct observation of Staphylococcus aureus cell wall digestion by lysostaphin
J. Bacteriol.
190
7904-7909
2008
Staphylococcus simulans
Manually annotated by BRENDA team
Cohen, D.N.; Sham, Y.Y.; Haugstad, G.D.; Xiang, Y.; Rossmann, M.G.; Anderson, D.L.; Popham, D.L.
Shared catalysis in virus entry and bacterial cell wall depolymerization
J. Mol. Biol.
387
607-618
2009
Salasvirus phi29
Manually annotated by BRENDA team
Placencia, F.X.; Kong, L.; Weisman, L.E.
Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin
Pediatr. Res.
65
420-424
2009
Staphylococcus simulans
Manually annotated by BRENDA team
Desbois, A.P.; Gemmell, C.G.; Coote, P.J.
In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections
Int. J. Antimicrob. Agents
35
559-565
2010
Staphylococcus simulans
Manually annotated by BRENDA team
Kokai-Kun, J.F.; Chanturiya, T.; Mond, J.J.
Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice
J. Antimicrob. Chemother.
64
94-100
2009
Staphylococcus simulans
Manually annotated by BRENDA team
Desbois, A.P.; Lang, S.; Gemmell, C.G.; Coote, P.J.
Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA)
J. Appl. Microbiol.
108
723-730
2010
Staphylococcus simulans
Manually annotated by BRENDA team
Gargis, S.R.; Heath, H.E.; LeBlanc, P.A.; Dekker, L.; Simmonds, R.S.; Sloan, G.L.
Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein
Appl. Environ. Microbiol.
76
6944-6946
2010
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Schmelcher, M.; Powell, A.M.; Becker, S.C.; Camp, M.J.; Donovan, D.M.
Chimeric phage lysins act synergistically with Lysostaphin to kill mastitis causing Staphylococcus aureus in murine mammary glands
Appl. Environ. Microbiol.
78
2297-22305
2012
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Miao, J.; Pangule, R.C.; Paskaleva, E.E.; Hwang, E.E.; Kane, R.S.; Linhardt, R.J.; Dordick, J.S.
Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications
Biomaterials
32
9557-9567
2011
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Aguinaga, A.; Francs, M.; Del Pozo, J.; Alonso, M.; Serrera, A.; Lasa, I.; Leiva, J.
Lysostaphin and clarithromycin: A promising combination for the eradication of Staphylococcus aureus biofilms
Int. J. Antimicrob. Agents
37
585-587
2011
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Bastos, M.; Coutinho, B.; Coelho, M.
Lysostaphin: A staphylococcal bacteriolysin with potential clinical applications
Pharmaceuticals
3
1139-1161
2010
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Huang, C.; Hsu, J.; Chung, P.; ChengWINSTON, T.; Jiang, Y.; Ju, Y.
Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus
Anim. Biotechnol.
24
129-147
2013
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Lu, H.; Gu, M.; Huang, Q.; Huang, J.; Lu, W.; Lu, H.; Huang, Q.
Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains
Antimicrob. Agents Chemother.
57
1872-1881
2013
Staphylococcus simulans (P10547), Staphylococcus simulans
Manually annotated by BRENDA team
Hertlein, T.; Sturm, V.; Lorenz, U.; Sumathy, K.; Jakob, P.; Ohlsen, K.
Bioluminescence and 19F magnetic resonance imaging visualize the efficacy of lysostaphin alone and in combination with oxacillin against Staphylococcus aureus in murine thigh and catheter-associated infection models
Antimicrob. Agents Chemother.
58
1630-1638
2014
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Chen, C.; Fan, H.; Huang, Y.; Peng, F.; Fan, H.; Yuan, S.; Tong, Y.
Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia
BioMed Res. Int.
2014
2014
2014
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Sabala, I.; Jonsson, I.; Tarkowski, A.; Bochtler, M.
Anti-staphylococcal activities of lysostaphin and LytM catalytic domain
BMC Microbiol.
12
97
2012
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Sabala, I.; Jagielska, E.; Bardelang, P.; Czapinska, H.; Dahms, S.; Sharpe, J.; James, R.; Than, M.; Thomas, N.; Bochtler, M.
Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans
FEBS J.
281
4112-4122
2014
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Kumar, A.; Khan, I.; Sharma, P.; Sumathy, K.; Ella, K.
Evaluation of activity of recombinant lysostaphin against isolates of meticillin-resistant Staphylococcus aureus from Indian hospitals
J. Med. Microbiol.
63
763-766
2014
Staphylococcus simulans
Manually annotated by BRENDA team
Filatova, L.Y.; Donovan, D.M.; Ishnazarova, N.T.; Foster-Frey, J.A.; Becker, S.C.; Pugachev, V.G.; Balabushevich, N.G.; Dmitrieva, N.F.; Klyachko, N.L.
A chimeric LysK-lysostaphin fusion enzyme lysing Staphylococcus aureus cells a study of both kinetics of inactivation and specifics of interaction with anionic polymers
Appl. Biochem. Biotechnol.
180
544-557
2016
Staphylococcus simulans
Manually annotated by BRENDA team
Wu, X.; Kwon, S.J.; Kim, D.; Zha, J.; Mora-Pale, M.; Dordick, J.S.
Unprotonated short-chain alkylamines inhibit staphylolytic activity of lysostaphin in a wall teichoic acid-dependent manner
Appl. Environ. Microbiol.
84
e00693-18
2018
Staphylococcus simulans
Manually annotated by BRENDA team
Boksha, I.S.; Lavrova, N.V.; Grishin, A.V.; Demidenko, A.V.; Lyashchuk, A.M.; Galushkina, Z.M.; Ovchinnikov, R.S.; Umyarov, A.M.; Avetisian, L.R.; Chernukha, M.I.u.; Shaginian, I.A.; Lunin, V.G.; Karyagina, A.S.
Staphylococcus simulans recombinant lysostaphin production, purification, and determination of antistaphylococcal activity
Biochemistry
81
502-510
2016
Staphylococcus simulans
Manually annotated by BRENDA team
Kulikov, S.; Subakaeva, E.; Zelenikhin, P.; Tyurin, Y.; Ilinskaya, O.
Depolymerized chitosan enhances the lysis of Staphylococcus aureus cells by lysostaphin
BioNanoSci.
8
1-4
2018
Staphylococcus simulans bv. staphylolyticus
-
Manually annotated by BRENDA team
Tossavainen, H.; Raulinaitis, V.; Kauppinen, L.; Pentikaeinen, U.; Maaheimo, H.; Permi, P.
Structural and functional insights into lysostaphin-substrate interaction
Front. Mol. Biosci.
5
60
2018
Staphylococcus simulans (P10547), Staphylococcus simulans
Manually annotated by BRENDA team
Sadoogh Abbasian, S.; Soufian, S.; Ghaznavi-Rad, E.; Abtahi, H.
High level activity of recombinant lysostaphin after computer simulation and additive-based refolding
Int. J. Pept. Res. Ther.
25
1241-1249
2019
Staphylococcus simulans
-
Manually annotated by BRENDA team
Narasimhaswamy, N.; Bairy, I.; Shenoy, G.; Bairy, L.
In vitro activity of recombinant lysostaphin in combination with linezolid, vancomycin and oxacillin against methicillin-resistant Staphylococcus aureus
Iran. J. Microbiol.
9
208-212
2017
Staphylococcus simulans
Manually annotated by BRENDA team
Ceotto-Vigoder, H.; Marques, S.L.; Santos, I.N.; Alves, M.D.; Barrias, E.S.; Potter, A.; Alviano, D.S.; Bastos, M.C.
Nisin and lysostaphin activity against preformed biofilm of Staphylococcus aureus involved in bovine mastitis
J. Appl. Microbiol.
121
101-114
2016
Staphylococcus simulans
Manually annotated by BRENDA team
Blazanovic, K.; Zhao, H.; Choi, Y.; Li, W.; Salvat, R.S.; Osipovitch, D.C.; Fields, J.; Moise, L.; Berwin, B.L.; Fiering, S.N.; Bailey-Kellogg, C.; Griswold, K.E.
Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance
Mol. Ther. Methods Clin. Dev.
2
15021
2015
Staphylococcus simulans
Manually annotated by BRENDA team
Grishin, A.V.; Lavrova, N.V.; Lyashchuk, A.M.; Strukova, N.V.; Generalova, M.S.; Ryazanova, A.V.; Shestak, N.V.; Boksha, I.S.; Polyakov, N.B.; Galushkina, Z.M.; Soboleva, L.A.; Vetchinin, S.S.; Pavlov, V.M.; Karyagina, A.S.; Lunin, V.G.
The influence of dimerization on the pharmacokinetics and activity of an antibacterial enzyme lysostaphin
Molecules
24
1879
2019
Staphylococcus simulans (P10547)
Manually annotated by BRENDA team
Jun, S.; Cho, S.; Park, Y.
Functionalization of lysostaphin on gold and silver nanoparticles and their in vitro antibacterial activities against methicillin-resistant Staphylococcus aureus
Nanosci. Nanotechnol. Lett.
7
433-440
2015
Staphylococcus simulans
-
Manually annotated by BRENDA team
Duman, Z.E.; Uenlue, A.; Cakar, M.M.; Uenal, H.; Binay, B.
Enhanced production of recombinant Staphylococcus simulans lysostaphin using medium engineering
Prep. Biochem. Biotechnol.
49
521-528
2019
Staphylococcus simulans (P10547), Staphylococcus simulans, Staphylococcus simulans NRRLB-2628 (P10547)
Manually annotated by BRENDA team
Chandra Ojha, S.; Imtong, C.; Meetum, K.; Sakdee, S.; Katzenmeier, G.; Angsuthanasombat, C.
Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans Adverse influence of Zn2+ on bacteriolytic activity
Protein Expr. Purif.
151
106-112
2018
Staphylococcus simulans (P10547), Staphylococcus simulans
Manually annotated by BRENDA team
Johnson, C.T.; Sok, M.C.P.; Martin, K.E.; Kalelkar, P.P.; Caplin, J.D.; Botchwey, E.A.; Garcia, A.J.
Lysostaphin and BMP-2 co-delivery reduces S. aureus infection and regenerates critical-sized segmental bone defects
Sci. Adv.
5
eaaw1228
2019
Staphylococcus simulans
Manually annotated by BRENDA team
Raulinaitis, V.; Tossavainen, H.; Aitio, O.; Juuti, J.T.; Hiramatsu, K.; Kontinen, V.; Permi, P.
Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family
Sci. Rep.
7
6020
2017
Staphylococcus aureus, Staphylococcus aureus NCTC 8325
Manually annotated by BRENDA team
Mitkowski, P.; Jagielska, E.; Nowak, E.; Bujnicki, J.M.; Stefaniak, F.; Niedzialek, D.; Bochtler, M.; Sabala, I.
Structural bases of peptidoglycan recognition by lysostaphin SH3b domain
Sci. Rep.
9
5965
2019
Staphylococcus simulans (P10547), Staphylococcus simulans
Manually annotated by BRENDA team